0001192482-15-000200.txt : 20150513 0001192482-15-000200.hdr.sgml : 20150513 20150513163703 ACCESSION NUMBER: 0001192482-15-000200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150512 FILED AS OF DATE: 20150513 DATE AS OF CHANGE: 20150513 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 DEDHAM STREET, SUITE 800 CITY: CANTON STATE: MA ZIP: 02021 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 780 DEDHAM STREET, SUITE 800 CITY: CANTON STATE: MA ZIP: 02021 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hirsch David CENTRAL INDEX KEY: 0001619884 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37372 FILM NUMBER: 15858911 MAIL ADDRESS: STREET 1: C/O LONGITUDE CAPITAL PARTNERS, LLC STREET 2: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-05-12 0001267565 COLLEGIUM PHARMACEUTICAL, INC COLL 0001619884 Hirsch David C/O LONGITUDE CAPITAL PARTNERS, LLC 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94024 1 0 1 0 Common Stock 2015-05-12 4 C 0 1860570 A 1860750 I By Longitude Venture Partners, L.P. Common Stock 2015-05-12 4 C 0 458102 A 2318672 I By Longitude Venture Partners, L.P. Common Stock 2015-05-12 4 C 0 741830 A 3060502 I By Longitude Venture Partners, L.P. Common Stock 2015-05-12 4 P 0 196070 12.00 A 3256572 I By Longitude Venture Partners, L.P. Common Stock 2015-05-12 4 C 0 37290 A 37290 I By Longitude Capital Associates, L.P. Common Stock 2015-05-12 4 C 0 9182 A 46472 I By Longitude Capital Associates, L.P. Common Stock 2015-05-12 4 C 0 14868 A 61340 I By Longitude Capital Associates, L.P. Common Stock 2015-05-12 4 P 0 3930 12.00 A 65270 I By Longitude Capital Associates, L.P. Series B Convertible Stock 2015-05-12 4 C 0 12837935 0 D Common Stock 1860570 0 I By Longitude Venture Partners, L.P. Series B Convertible Stock 2015-05-12 4 C 0 257303 0 D Common Stock 37290 0 I By Longitude Capital Associates, L.P. Series C Convertible Stock 2015-05-12 4 C 0 3160905 0 D Common Stock 458102 0 I By Longitude Venture Partners, L.P. Series C Convertible Stock 2015-05-12 4 C 0 63356 0 D Common Stock 9182 0 I By Longitude Capital Associates, L.P. Series D Convertible Stock 2015-05-12 4 C 0 5045381 0 D Common Stock 741830 0 I By Longitude Venture Partners, L.P. Series D Convertible Stock 2015-05-12 4 C 0 101128 0 D Common Stock 14868 0 I By Longitude Capital Associates, L.P. All series of Convertible Preferred Stock automatically converted into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis immediately prior to the closing of the initial public offering and had no expiration date. Reflects the conversion of preferred stock into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis which became effective on May 12, 2015. The shares are held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. (collectively, the "Longitude Funds"). Longitude Capital Partners, LLC is the general partner of the Longitude Funds. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of Longitude Capital Partners, LLC and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by the reporting persons. David Hirsch is a member of Longitude Capital Partners, LLC. Dr. Hirsch disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. /s/ Paul Brannelly as Attorney-In-Fact For David Hirsch 2015-05-13